Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01726985 · ClinicalTrials.gov registry record
Model for Heart Failure ExAcerbation Reduction Trial
A clinical trial, sponsored by Cleveland Clinic Florida.
- Completed
- Registry status
- 230
- Enrollment target
NCT01726985: Completed study, sponsored by Cleveland Clinic Florida.
NCT01726985 is a clinical trial that has completed, run by Cleveland Clinic Florida. The registered enrollment target is 230 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01726985 has completed, sponsored by Cleveland Clinic Florida.
- COMPLETED
- Registry status
- 230 participants
- Enrollment target
Study Summary
Heart failure is the leading cause of hospitalizations and readmissions in the United States and is a tremendous economic strain on our healthcare system. There is currently, based on national averages, a 30% readmission rate and 10% mortality rate within 3 months of being hospitalized for heart failure. Retrospective studies have shown benefit to using biomarkers such as BNP to guide inpatient heart failure management. Our own CCF retrospective study showed that decreasing NT-ProBNP by 23%, making patients fluid negative by more than 1.3L, and discharging patients with serum sodium above 135 reduces readmission rates significantly. The purpose of this study is to prospectively use the above mentioned goals in the treatment of heart failure in order to reduce heart failure readmission and mortality rates.
Interventions
- OTHER Parameter Based Clinical Disposition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-10 |
What the finished NCT01726985 record still lists
NCT01726985 is an observational study that tracks outcomes without assigning an intervention. The registered 230 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Parameter Based Clinical Disposition is the first listed.
NCT01726985 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01726985 about?
NCT01726985 is a clinical study titled "Model for Heart Failure ExAcerbation Reduction Trial". Heart failure is the leading cause of hospitalizations and readmissions in the United States and is a tremendous economic strain on our healthcare system. There is currently, based on national averages, a 30% readmission rate and 10% mortality rate within 3 months of being hospitalized for heart fai...
What is the current status of trial NCT01726985?
This trial is currently completed. The enrollment target is 230 participants. The study started on 2012-11. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01726985?
The interventions under investigation include: Parameter Based Clinical Disposition (OTHER).
Who is sponsoring clinical trial NCT01726985?
This trial is sponsored by Cleveland Clinic Florida, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia